Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seaman

Showing results (121-130 of 415) with videos related to

Pageof 42
Sort By:
Plos Pathogens|August 11, 2011
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytesGeoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Mucosal Immunology|September 11, 2009
Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responsesM P Cranage, C A Fraser, Z Stevens, et al.
Journal of Virology|April 11, 2014
Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routesJamie F S Mann, Paul F McKay, Anezka Fiserova, et al.
Applied Microbiology and Biotechnology|October 24, 2019
A microbial expression system for high-level production of scFv HIV-neutralizing antibody fragments in Escherichia coliMarloes L C Petrus, Lukas A Kiefer, Pranav Puri, et al.
Plos One|October 22, 2011
Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtainedSunita S Balla-Jhagjhoorsingh, Betty Willems, Liesbeth Heyndrickx, et al.
Journal of Virology|June 4, 2010
Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeysSallie R Permar, Andrew B Wilks, Elizabeth P Ehlinger, et al.
Elife|April 12, 2021
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadthDeniz Cizmeci, Giuseppe Lofano, Evan Rossignol, et al.
Cell Reports|May 16, 2025
Mapping essential somatic hypermutations in a CD4-binding site bNAb informs HIV-1 vaccine designKim-Marie A Dam, Harry B Gristick, Yancheng E Li, et al.
Pageof 42

Showing results (121-130 of 415) with videos related to

Sort By:
Pageof 42
Plos Pathogens|August 11, 2011
Thy1+ NK [corrected] cells from vaccinia virus-primed mice confer protection against vaccinia virus challenge in the absence of adaptive lymphocytesGeoffrey O Gillard, Maytal Bivas-Benita, Avi-Hai Hovav, et al.
Elife|May 27, 2017
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodiesHaoqing Wang, Harry B Gristick, Louise Scharf, et al.
Vaccine|February 22, 2014
Comparison of multiple adjuvants on the stability and immunogenicity of a clade C HIV-1 gp140 trimerJoseph P Nkolola, Ann Cheung, James R Perry, et al.
Mucosal Immunology|September 11, 2009
Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responsesM P Cranage, C A Fraser, Z Stevens, et al.
Journal of Virology|April 11, 2014
Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routesJamie F S Mann, Paul F McKay, Anezka Fiserova, et al.
Applied Microbiology and Biotechnology|October 24, 2019
A microbial expression system for high-level production of scFv HIV-neutralizing antibody fragments in Escherichia coliMarloes L C Petrus, Lukas A Kiefer, Pranav Puri, et al.
Plos One|October 22, 2011
Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtainedSunita S Balla-Jhagjhoorsingh, Betty Willems, Liesbeth Heyndrickx, et al.
Journal of Virology|June 4, 2010
Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeysSallie R Permar, Andrew B Wilks, Elizabeth P Ehlinger, et al.
Elife|April 12, 2021
Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadthDeniz Cizmeci, Giuseppe Lofano, Evan Rossignol, et al.
Cell Reports|May 16, 2025
Mapping essential somatic hypermutations in a CD4-binding site bNAb informs HIV-1 vaccine designKim-Marie A Dam, Harry B Gristick, Yancheng E Li, et al.
Pageof 42